Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8(9):11884-94.

Capote-Moreno A, Brabyn P, Muñoz-Guerra MF, Sastre-Pérez J, Escorial-Hernandez V, Rodríguez-Campo FJ, García T, Naval-Gías L. Oral squamous cell carcinoma: epidemiological study and risk factor assessment based on a 39-year series. Int J Oral Maxillofac Surg. 2020;49(12):1525-34. https://doi.org/10.1016/j.ijom.2020.03.009

He B, Zhao Z, Cai Q, Zhang Y, Zhang P, Shi S, Xie H, Peng X, Yin W, Tao Y, Wang X. miRNA-based biomarkers, therapies, and resistance in Cancer. Int J Biol Sci. 2020;16(14):2628-47. https://doi.org/10.7150/ijbs.47203

Iacona JR, Lutz CS. miR-146a-5p: Expression, regulation, and functions in cancer. Wiley Interdiscip Rev RNA. 2019;10(4):e1533. https://doi.org/10.1002/wrna.1533

Wang L, Chen Y, Yan Y, Guo X, Fang Y, Su Y, Wang L, Pathak JL, Ge L. miR-146a Overexpression in Oral Squamous Cell Carcinoma Potentiates Cancer Cell Migration and Invasion Possibly via Targeting HTT. Front Oncol. 2020;10:585976. https://doi.org/10.3389/fonc.2020.585976

Lin SC, Liu CJ, Ji SH, Hung WW, Liu YC, Chang SR, Tu HF, Chang KW. The upregulation of oncogenic miRNAs in swabbed samples obtained from oral premalignant and malignant lesions. Clin Oral Investig 2022;26(2):1343-51. https://doi.org/10.1007/s00784-021-04108-y

Piotrowski I, Zhu X, Saccon TD. miRNAs as Biomarkers for Diagnosing and Predicting Survival of Head and Neck Squamous Cell Carcinoma Patients. Cancer (Basel) 2021;13(16):3980. https://doi.org/10.3390/cancers13163980

Shi Z, Johnson JJ, Jiang R, Liu Y, Stack MS. Decrease of miR-146a is associated with the aggressiveness of human oral squamous cell carcinoma. Arch Oral Biol. 2015;60(9):1416-27. https://doi.org/10.1016/j.archoralbio.2015.06.007

Min SK, Jung SY, Kang HK, Park SA, Lee JH, Kim MJ, Min BM. Functional diversity of miR-146a-5p and TRAF6 in normal and oral cancer cells. Int J Oncol. 2017;51(5):1541-52. https://doi.org/10.3892/ijo.2017.4124

Liu YT, Yu CC, Lu MY, Chao SC, Liao YW, Yu CH, Lee YH. miR-146a participates in the regulation of cancer stemness of oral carcinoma cells. J Dent Sci. 2023;18(2):503-9. https://doi.org/10.1016/j.jds.2022.09.001

Ghuwalewala S, Ghatak D, Das S, Roy S, Das P, Butti R, Gorain M, Nath S, Kundu GC, Roychoudhury S. MiRNA-146a/AKT/β-Catenin Activation Regulates Cancer Stem Cell Phenotype in Oral Squamous Cell Carcinoma by Targeting CD24. Front Oncol. 2021;11:651692. https://doi.org/10.3389/fonc.2021.651692

Zhu FY, Gan CW, Wang MX, Sun BC, Li FJ, Qiu YH, Wang K. MiR-146a-5p inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells by regulating NF-κB signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(7):3717-23. https://doi.org/10.26355/eurrev_202004_20835

Wang F, Ye LJ, Wang FJ. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells. Environ Toxicol 2020;35(10):1050-7. https://doi.org/10.1002/tox.22941

Hung PS, Liu CJ, Chou CS, Kao SY, Yang CC, Chang KW, Chiu TH, Lin SC. miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes. PLoS One. 2013;8(11):e79926. https://doi.org/10.1371/journal.pone.0079926

Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010;10(6):389-402. https://doi.org/10.1038/nrc2867

Zhang X, He R, Ren F, Tang R, Chen G. Association of miR-146a rs2910164 polymorphism with squamous cell carcinoma risk: a meta-analysis. J Buon. 2015;20(3):829-41.

Hung PS, Chang KW, Kao SY, Chu TH, Liu CJ, Lin SC. Association between the rs2910164 polymorphism in pre-mir-146a and oral carcinoma progression. Oral Oncol. 2012;48(5):404-8. https://doi.org/10.1016/j.oraloncology.2011.11.019

Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2008;105(20):7269-74. https://doi.org/10.1073/pnas.0802682105

Stojkovic G, Jovanovic I, Dimitrijevic M, Jovanovic J, Tomanovic N, Stankovic A, Arsovic N, Boricic I, Zeljic K. Meta-signature guided investigation of miRNA candidates as potential biomarkers of oral cancer. 2023;29(4):1550-64. https://doi.org/10.1111/odi.14185

Budczies J, Klauschen F, Sinn BV, Győrffy B, Schmitt WD, Darb-Esfahani S, Denkert C. Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS One. 2012;7(12):e51862. https://doi.org/10.1371/journal.pone.0051862

Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175-91. https://doi.org/10.3758/bf03193146

Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149-60. https://doi.org/10.3758/brm.41.4.1149

Svoronos AA, Engelman DM, Slack FJ. OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer. Cancer Res. 2016;76(13):3666-70. https://doi.org/10.1158/0008-5472.can-16-0359

Berkel C, Cacan E. Transcriptomic analysis reveals tumor stage- or grade-dependent expression of miRNAs in serous ovarian cancer. 2021;34(3):862-77. https://doi.org/10.1007/s13577-021-00486-3

Gissi DB, Morandi L. A Noninvasive Test for MicroRNA Expression in Oral Squamous Cell Carcinoma. Int J Mol Sci 2018;19(6):1789. https://doi.org/10.3390/ijms19061789

Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6(5):963-8. https://doi.org/10.1002/1097-0142(195309)6:5<963::aid-cncr2820060515>3.0.co;2-q

Shen J, Ambrosone CB, DiCioccio RA, Odunsi K, Lele SB, Zhao H. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis. 2008;29(10):1963-6. https://doi.org/10.1093/carcin/bgn172

Xu B, Feng NH, Li PC, Tao J, Wu D, Zhang ZD, Tong N, Wang JF, Song NH, Zhang W, Hua LX, Wu HF. A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo. Prostate. 2010;70(5):467-72. https://doi.org/10.1002/pros.21080

Du L, Yang Y, Xiao X, Wang C, Zhang X, Wang L, Zhang X, Li W, Zheng G, Wang S, Dong Z. Sox2 nuclear expression is closely associated with poor prognosis in patients with histologically node-negative oral tongue squamous cell carcinoma. Oral Oncol. 2011;47(8):709-13. https://doi.org/10.1016/j.oraloncology.2011.05.017

Han X, Fang X, Lou X, Hua D, Ding W, Foltz G, Hood L, Yuan Y, Lin B. Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients. PLoS One. 2012;7(8):e41335. https://doi.org/10.1371/journal.pone.0041335

Lazarevic M, Milosevic M, Jelovac D, Milenkovic S, Tepavcevic Z, Baldan F, Suboticki T, Toljic B, Trisic D, Dragovic M, Damante G, Milasin J. Marked epithelial to mesenchymal transition in surgical margins of oral cancer-an in vitro study. Oncol Lett. 2020;19(6):3743-50. https://doi.org/10.3892/ol.2020.11494